ETOMIDATE INJECTION USP 2 MG
ETOMIDATE : 2 MG · DIN 02525453 · MARCAN PHARMACEUTICALS INC
Health Canada status: CANCELLED POST MARKET
What is ETOMIDATE INJECTION USP?
ETOMIDATE INJECTION USP 2 MG contains ETOMIDATE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02525453, held by MARCAN PHARMACEUTICALS INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 18-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02525453 |
|---|---|
| Brand name | ETOMIDATE INJECTION USP |
| Generic / active ingredient | ETOMIDATE : 2 MG |
| Manufacturer | MARCAN PHARMACEUTICALS INC |
| Strength | 2 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | N01AX07 ETOMIDATE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 18-Mar-2026 |
Is ETOMIDATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N01AX07 ETOMIDATE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ETOMIDATE INJECTION, USP | 2 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02537508 |
| TOMVI | 2 MG | SOLUTION | STERIMAX INC | MARKETED | DIN 02498650 |
Who else supplies ETOMIDATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ETOMIDATE appears in 4 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.